| Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ... New england journal of medicine 379 (1), 11-21, 2018 | 2376 | 2018 |
| Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ... Circulation 139 (4), 431-443, 2019 | 414 | 2019 |
| Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry G Ntaios, P Michel, G Georgiopoulos, Y Guo, W Li, J Xiong, P Calleja, ... Stroke 51 (9), e254-e258, 2020 | 332 | 2020 |
| “Red‐flag” symptom clusters in transthyretin familial amyloid polyneuropathy I Conceição, A González‐Duarte, L Obici, HHJ Schmidt, D Simoneau, ... Journal of the Peripheral Nervous system 21 (1), 5-9, 2016 | 294 | 2016 |
| Evolving landscape in the management of transthyretin amyloidosis PN Hawkins, Y Ando, A Dispenzeri, A Gonzalez-Duarte, D Adams, ... Annals of medicine 47 (8), 625-638, 2015 | 250 | 2015 |
| Recurrent primary cerebral hemorrhage: frequency, mechanisms, and prognosis A González-Duarte, C Cantú, JL Ruíz-Sandoval, F Barinagarrementeria Stroke 29 (9), 1802-1805, 1998 | 156 | 1998 |
| Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial D Adams, IL Tournev, MS Taylor, T Coelho, V Planté-Bordeneuve, ... Amyloid 30 (1), 18-26, 2023 | 136 | 2023 |
| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 115 | 2021 |
| Diagnosis and management of HIV-associated neuropathy A Gonzalez-Duarte, J Robinson-Papp, DM Simpson Neurologic clinics 26 (3), 821-832, 2008 | 89 | 2008 |
| Development of measures of polyneuropathy impairment in hATTR amyloidosis: from NIS to mNIS+ 7 PJB Dyck, A González-Duarte, L Obici, M Polydefkis, JF Wiesman, ... Journal of the neurological sciences 405, 116424, 2019 | 84 | 2019 |
| Is' happy hypoxia'in COVID-19 a disorder of autonomic interoception? A hypothesis A González-Duarte, L Norcliffe-Kaufmann Clinical Autonomic Research 30, 331-333, 2020 | 78 | 2020 |
| Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City FD Flores-Silva, M Garcia-Grimshaw, SI Valdes-Ferrer, ... PLoS One 16 (4), e0247433, 2021 | 68 | 2021 |
| Clinical description of seizures in patients with systemic lupus erythematosus A González-Duarte, CG Cantú-Brito, L Ruano-Calderón, G García-Ramos European neurology 59 (6), 320-323, 2008 | 67 | 2008 |
| Neurological manifestations temporally associated with SARS-CoV-2 infection in pediatric patients in Mexico AE Sánchez-Morales, M Urrutia-Osorio, E Camacho-Mendoza, ... Child's Nervous System 37, 2305-2312, 2021 | 66 | 2021 |
| Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis L Obici, JL Berk, A González-Duarte, T Coelho, J Gillmore, HHJ Schmidt, ... Amyloid 27 (3), 153-162, 2020 | 64 | 2020 |
| Managing HIV peripheral neuropathy A Gonzalez-Duarte, K Cikurel, DM Simpson Current HIV/AIDS Reports 4 (3), 114-118, 2007 | 54 | 2007 |
| Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis) A Gonzalez-Duarte Clinical Autonomic Research 29, 245-251, 2019 | 48 | 2019 |
| Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis A González-Duarte, JL Berk, D Quan, ML Mauermann, HH Schmidt, ... Journal of neurology 267, 703-712, 2020 | 45 | 2020 |
| Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management JA Palma, A Gonzalez-Duarte, H Kaufmann Clinical Autonomic Research 29, 33-44, 2019 | 44 | 2019 |
| Clinical description of intracranial hemorrhage associated with bleeding disorders A González-Duarte, GS García-Ramos, SI Valdés-Ferrer, C Cantú-Brito Journal of Stroke and Cerebrovascular Diseases 17 (4), 204-207, 2008 | 42 | 2008 |
